Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

Related Articles by Review for PubMed (Select 12807364)

1.

Costs of bipolar disorder.

Kleinman L, Lowin A, Flood E, Gandhi G, Edgell E, Revicki D.

Pharmacoeconomics. 2003;21(9):601-22. Review.

PMID:
12807364
2.

[Bipolar I disorder in France: prevalence of manic episodes and hospitalisation-related costs].

de ZĂ©licourt M, Dardennes R, Verdoux H, Gandhi G, Papatheodorou ML, Edgell ET, Khoshnood B, Chomette E, Even C, Fagnani F.

Encephale. 2003 May-Jun;29(3 Pt 1):248-53. Review. French.

PMID:
12876549
3.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
4.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
5.

Bipolar disorder: disease burden.

Sajatovic M.

Am J Manag Care. 2005 Jun;11(3 Suppl):S80-4. Review.

6.

Economic costs of diabetes in the U.S. In 2007.

American Diabetes Association.

Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Review. Erratum in: Diabetes Care. 2008 Jun;31(6):1271.

PMID:
18308683
7.
8.

[Direct and indirect diabetes costs in the world].

Logminiene Z, Norkus A, Valius L.

Medicina (Kaunas). 2004;40(1):16-26. Review. Lithuanian.

9.

Bipolar disorder--costs and comorbidity.

Hirschfeld RM, Vornik LA.

Am J Manag Care. 2005 Jun;11(3 Suppl):S85-90. Review.

10.

Estimating the cost of epilepsy in Europe: a review with economic modeling.

Pugliatti M, Beghi E, Forsgren L, Ekman M, Sobocki P.

Epilepsia. 2007 Dec;48(12):2224-33. Review.

PMID:
18088267
11.

Diagnostic features, prevalence, and impact of bipolar disorder.

Ketter TA.

J Clin Psychiatry. 2010 Jun;71(6):e14. doi: 10.4088/JCP.8125tx11c. Review.

PMID:
20573324
12.

Breast cancer management: quality-of-life and cost considerations.

Radice D, Redaelli A.

Pharmacoeconomics. 2003;21(6):383-96. Review.

PMID:
12678566
13.

Bipolar II disorder : epidemiology, diagnosis and management.

Benazzi F.

CNS Drugs. 2007;21(9):727-40. Review.

PMID:
17696573
14.

[The costs of bipolar disorder].

Dardennes R, Thuile J, Friedman S, Guelfi JD.

Encephale. 2006 Jan-Feb;32(1 Pt 1):18-25. Review. French.

PMID:
16633287
15.

The economic burden of allergic rhinitis: a critical evaluation of the literature.

Reed SD, Lee TA, McCrory DC.

Pharmacoeconomics. 2004;22(6):345-61. Review.

PMID:
15099121
16.
17.

Prevalence and impact of comorbid anxiety and bipolar disorder.

Keller MB.

J Clin Psychiatry. 2006;67 Suppl 1:5-7. Review.

PMID:
16426110
19.

A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.

Bridle C, Palmer S, Bagnall AM, Darba J, Duffy S, Sculpher M, Riemsma R.

Health Technol Assess. 2004 May;8(19):iii-iv, 1-187. Review.

20.

Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies.

Krauth C, Jalilvand N, Welte T, Busse R.

Pharmacoeconomics. 2003;21(14):1001-24. Review.

PMID:
13129414
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk